Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (2852)	11/16/1997 10:31:00 PM
From: JOHN W.	Read Replies (1) of 6136

Subject: Christmas rally Date: Sun, Nov 16, 1997 21:07 EST From: Taurus8266 Message-id: <19971117020700.VAA02373@ladder02.news.aol.com> As first reported on SI, AGPH made a historical presentation this weekend to a group of `advisers' of data showing that Thymitaq works great, they may have a `cure' for the common cold, and AG3340 is the next best thing to penicillin_and without the toxicity. The incredulousness of Agouron presenting such profound data in a tawdry hotel outside the confines of a scientific meeting; this is so....uncharacteristic of the Agouron corporate culture. Who knows what analysts may have been lurking the halls, or hiding behind closed doors in the men's room. Is Agouron finally playing the game? Was this just a sounding board for some obscure, scientific meeting upcoming in Europe? Given the magnitude of the data and its material effect on the company_ala British Biotech_is not AGPH legally obligated to issue a PR once this info has `leaked'_ala Coulter Pharm??

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next